2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2676
  



  

  
Submitter : 
  

  
Mr. Robert Connelly
  

  
Date & Time: 
  

  
12/06/2006 09:12:13
  



  

  
Organization : 
  

  
Mr. Robert Connelly
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Since there are alternative cell lines to use to manufacture vaccines other than cell lines from aborted fetuses, I request that the FDA establish guidelines to create vaccines from non-objectionable sources.